idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
03/29/2023 10:30

Kick-off of the new Marie Skłodowska-Curie Doctoral Network "ReWIRE"

Fabio Sentek Presse- und Öffentlichkeitsarbeit
DWI - Leibniz-Institut für Interaktive Materialien

    For the next four years, 13 project members and ten associated partners from science and industry will work closely together in the "ReWIRE" project, coordinated by DWI - Leibniz Institute for Interactive Materials in Aachen, Germany. Through ReWIRE, next-generation scientists will be trained to develop translational breakthrough therapeutic solutions for patients with paralysis caused by traumatic spinal cord injuries.

    The new Doctoral Network "Technology-driven combinatorial therapy to rewire the spinal cord after injury" (ReWIRE) receives funding of €2.67 million from the European Union as part of the "Marie Skłodowska-Curie Actions" Horizon Europe initiative. Furthermore, the State Secretariat for Education, Research, and Innovation (SERI) in Switzerland and UK Research and Innovation (UKRI) in the United Kingdom support this action with additional CHF 1.28 million and £530,000, respectively.

    The consortium and associated partners will enable 16 Ph.D. students around Europe, the United Kingdom, and Switzerland to receive comprehensive, structured training with a well-designed curriculum and research plan, on-site courses and workshops, project meetings, and research rotations throughout Europe, the United States of America, and Canada. The goal is to bring combinatorial spinal cord injury therapies from the laboratory to the bedside on time while developing new approaches to regenerate the spinal cord after injury.

    "We jointly assembled an internationally renowned team of researchers dedicated to improving the lives of people after spinal cord injury, each with their core expertise in scar tissue modulation, regenerative biomaterials, neuroprosthetics, and robotics. By joining forces, we aim to fill gaps in traditional education programs and advance research and development expertise for medical products and therapies. This doctoral network will contribute significantly to bringing Europe to the forefront of spinal cord injury therapy" says Prof. Dr.-Ing. Laura De Laporte, Member of the Scientific Board at the DWI-Leibniz Institute for Interactive Materials and coordinator of ReWIRE.

    In addition to the DWI – Leibniz Institute, the EU-funded project partners include the Technical University of Hamburg, Biosynth BV, ONWARD Medical NV, Commissariat à l'énergie atomique et aux énergies alternatives, Eindhoven University of Technology, Scuola Superiore Sant'Anna di Studi Universitari e di Perfezionamento and Wearable Robotics srl, as well as nationally funded partners from Switzerland (École Polytechnique Fédérale de Lausanne, Centre hospitalier universitaire Vaudois Lausanne, University of Zurich) and the UK (Imperial College London, King’s College London).

    "We are thrilled to participate in this exciting program with leading institutions for spinal cord research. We have already hired a Ph.D. candidate who is working on closed-loop control modalities for spinal cord stimulation in a jointly supervised project by RWTH Aachen University (Aachen, Germany), EPFL (Lausanne, Switzerland) and CHUV (Lausanne, Switzerland)”, said Joachim von Zitzewitz, Director Systems Engineering of ONWARD.


    Contact for scientific information:

    Prof. Dr.-Ing Laura De Laporte


    More information:

    http://cordis.europa.eu/project/id/101073374
    http://www.dwi.rwth-aachen.de/en/page/rewire
    http://euraxess.ec.europa.eu/jobs/search


    Images

    Symbolic image: ARC trial participant in active therapy ONWARD's ARC Therapy is designed to deliver targeted, programmed spinal cord stimulation to restore movement and other functions in people with spinal cord injury.
    Symbolic image: ARC trial participant in active therapy ONWARD's ARC Therapy is designed to deliver ...

    ONWARD Medical NV


    Criteria of this press release:
    Business and commerce, Journalists, Scientists and scholars, Students, all interested persons
    Biology, Chemistry, Mechanical engineering, Medicine, Sport science
    transregional, national
    Cooperation agreements, Research projects
    English


     

    Symbolic image: ARC trial participant in active therapy ONWARD's ARC Therapy is designed to deliver targeted, programmed spinal cord stimulation to restore movement and other functions in people with spinal cord injury.


    For download

    x

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).